[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News and Perspectives
July 7, 2010

Program Seeks to Enlist Physicians to Flag Questionable Promotion of Drugs

JAMA. 2010;304(1):28-29. doi:10.1001/jama.2010.861

In an effort to expand its reach in spotting questionable advertising and promotion of prescription drugs, the US Food and Drug Administration (FDA) is asking physicians and other health care professionals to join a kind of pharmaceutical neighborhood watch.

The Bad Ad Program, launched May 11, is the FDA's effort to better educate physicians and other health care professionals about what they can do to help the agency ensure that promotion of prescription drugs is not deceptive. It is encouraging them to report back to the agency about activities and messages they consider false or misleading, not only in print and broadcast advertising, but also during in-person activities, such as detailing.

First Page Preview View Large
First page PDF preview
First page PDF preview
×